Effervescent Floating Drug Delivery System: A review by Pakhale, Nilesh V et al.
Pakhake et al                                                                                                       Journal of Drug Delivery & Therapeutics. 2019; 9(3-s):836-838 
ISSN: 2250-1177                                                                                  [836]                                                                                      CODEN (USA): JDDTAO 
Available online on 15.06.2019 at http://jddtonline.info 
Journal of Drug Delivery and Therapeutics 
Open Access to Pharmaceutical and Medical Research 
© 2011-18, publisher and licensee JDDT, This is an Open Access article which permits unrestricted 
non-commercial use, provided the original work is properly cited 
Open  Access                                                                                                                                                           Review Article 
Effervescent Floating Drug Delivery System: A review 
Pakhale Nilesh V1, Gondkar S.B1, Saudagar R.B.*2                                                       
1 Department of Pharmaceutics, R.G. Sapkal College of Pharmacy, Anjaneri-4222213, Dist.-Nashik, Maharashtra, India  
2 Department of Pharmaceutical Chemistry, R.G. Sapkal College of Pharmacy, Anjaneri-4222213, Dist.-Nashik, Maharashtra, India 
 
ABSTRACT 
Effervescent floating drug delivery systems release gas CO2, thus reduce the density of the system and remain buoyant in the stomach 2 for a 
prolonged period of time and released the drug slowly at a desired rate so it can be used to prolong the gastric residence time in order to 
improve the bioavailability of drug. In the present article we will discuss in detail about effervescent agent and mechanism of effervescent 
floating drug delivery system. Oral sustained release gastro-retentive dosage forms offer many advantages for drugs with the absorption from 
upper parts of the gastro intestinal tract. Gastric emptying is a complex process and it is highly variable. The floating drug delivery systems are 
useful methods to avoid this variability which increases the retention time of the drug delivery systems for more than 12 hours.  This review 
article is in pursuit of giving detailed information on the pharmaceutical basis of their design, classification, advantages, in vitro and in vivo 
evaluation parameters, and application of floating systems, and applications of these systems. These systems are useful to several problems 
encountered during the development of a pharmaceutical dosage form and the future potential of FDDS. At attempt has been made in this 
review article to introduce the readers to current development in floating drug delivery system, 
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The floating drug delivery system is a useful approach to 
avoid variability. Floating drug delivery systems are low-
density systems that have able to keep the float over the 
gastric fluid and remain buoyant in the stomach without 
affecting the gastric emptying rate for a prolonged period of 
time. This system faced to a several difficulties in designing 
control drug delivery system for better absorption and 
increasing bioavailability. The floating system is allow to 
float on the gastric fluid, the drug is released slowly from the 
system for the prolong duration of action.(1-2) The 
Effervescent floating tablets can be used as alternative 
dosage form to minimize some problems associated with 
conventional dosage forms. The Effervescent floating tablets 
also reduce fluctuations of drug concentration and can be 
used to increase the bioavailability of drug4. 
Drug absorption from the gastrointestinal tract is a complex 
procedure and is subject to many variables.Gastroretentive 
systems can remain in the gastric region for several hours 
and hence significantly prolong the gastric residence time of 
drugs. The drug is released slowly as desired rate from the 
system and after released of drug the residual system is 
emptied from the stomach.e.g. Chitosan and effervescent 
components such as sodium bicarbonate and citric or 
tartaric acid or matrices containing chambers of liquid those 
gasify at body temperature. Floating drug delivery system 
provides local delivery to specific region like stomach and 
proximal small intestine and it’s also shows better 
bioavailability, improved therapeutic activity and substantial 
benefits to patients.4-5 
Advantages of Effervescent Floating drug delivery 
system 
 Increases the oral bioavailability of drug. 
 Enhanced first pass biotransformation. 
 Sustained drug delivery/ reduced frequency of dosing. 
 Reduced fluctuations of drug concentration. 
 Improved receptor activation selectivity. 
 Reduced counter-activity of body. 
 Extended time over critical (Effective) concentration. 
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 Minimized adverse activity at the colon. 
 Receptor activation selectivity is improved.    
Factor affecting the Gastric residence time of 
Effervescent floating drug delivery system1-4  
 Nature of Meal: Feeding of indigestible polymers of 
fatty acid salts can change the motility pattern of the 
stomach to a fed state, thus decreasing the gastric 
emptying time   
 Frequency of Feed: when successive meals are given, 
the GRT can increase by over 40 minutes compared 
with a single meal because of the low frequency of 
migrating myoelectric complex. 
 Caloric content: GRT can be increased by 4 to 10 hrs 
with that is high in protein and fats. 
 Age: Elderly People, especially those over 70, have a 
significantly longer GRT.  
 Fed and Unfed State: Under fasting conditions, the GI 
motility is characterized by periods of strong motor 
activity or the migrating myoelectric complexes (MMC) 
that occurs every 1.5 to 2 hours. 
 Posture:  Posture on GRT, and found no significant 
difference in the mean GRT for individuals in upright, 
ambulatory and supine state 
Mechanism of Floating Effervescent Tablets: 
After administration of effervescent floating dosage form 
coming in contact with the gastric fluid the dosage form get 
swells up and the slowly release of the drug without 
disintegration of the tablet takes place. When the tablet 
comes in the contact of gastric fluid, it produces 
effervescence by releasing CO2 gas. When the fluid 
penetrates into the tablet, tablet starts to float1. 
     
        
 
This results in an increased GRT and a better control of the 
fluctuations in plasma drug concentration5. 
              F = F buoyancy - F gravity = (Df - Ds) gv--- (1) 
Where, F= total vertical force, 
              Df = fluid density,  
              Ds =object density,  
              v = volume and 
              g = acceleration due to gravity. 
Method of Preparation of Floating Effervescent Tablets 
 By direct compression 
 By wet granulation 
 Dry granulation 
Direct compression: The processing of drug with 
excipient can be achieved without any need of granulation 
and related unit operations. This procedure is called direct 
compression and it is used in the manufacture of tablet when 
formulation ingredients can flow uniformly into a die cavity. 
Wet granulation: The granulating fluid can be used alone or 
as a solvent containing binder or granulating agent.Powder 
mixing, in conjunction with the cohesive properties of the 
granulating agent, enables the formation of granules.  
Dry Granulation:. the process involves compaction of 
powder particles into large pieces or compacts which are 
subsequently broken down into granules to produce 
granules that can be further processed into dosage forms. 
Polymer used in floating  drug delivery system 
Floating drug delivery system are also called as gastro 
retentive drug delivery sytem. As we know that FDDS is an 
approach to achieve drug release for long duration. 
Polymers, which can be successfully used in floating drug 
delivery system andAcrylic polymers are widely used for the 
preparation of floating microspheres14. Xanthan gum,gellan 
gum or synthethic polymer such as HPMC (K4M, K15M, 
K100M), Carbopol 934p, polyvinylalcohol, polyamides, 
polycarbonates, polymethacrylic acid8. 
Evalution of floating drug delivery system 
Various Parameter used in evalution of effervescent floating 
tablet.  
Pre-compression parameter: 
 Pre-compression parameter include in effervescent floating 
tablet are flow properties include bulk density,tapped 
density,hausner ratio,carr’s index4. 
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Post-compression parameter: 
1.Swelling index: There are the dosage forms, which after 
swallowing swell to an extent that prevents their exit from 
the pylorus. 
2.Content uniformity,hardness,friability(Tablets):The 
tests are performed as per described in specified 
monographs.11 
 3. Floating lag time: The test for floating time 
measurement is usually performed in stimulated gastric 
fluid or 0.1 mole.lit-1 HCl maintained at 370C. It is 
determined by using USP dissolution apparatus containing 
900 ml of 0.1 mole.lit- 1 HCl as a dissolution medium at 
370C.. 
4. In vitro dissolution: Dissolution study is carried out in 
USP dissolution testing apparatus II (paddle type). 
Dissolution study was performed using 900ml 0.1N HCL, at 
50 rpm. A 5ml of sample was withdrawn from the 
dissolution apparatus at a predetermined interval and the 
sink condition is maintained by adding same volume of 
dissolution medium.1 
5. Drug release: It is important test for in vitro drug release 
study and carried out in gastric fluids and intestinal fluids 
maintained at 370 C. Dissolution tests are performed using 
the USP dissolution apparatus10 
6.Measurement of buoyancy capabilities: The floating 
behaviour was evaluated with resultant weight 
measurements.. The results showed that higher molecular 
weight polymers with slower rate of hydration had 
enhanced floating behaviour and it was observed more in 
simulated meal medium compared to deionised water3. 
Application of  floating drug delivery system 
1.Enhanced Bioavailability: 
The several different processes related with absorption and 
transit of drug in the GIT,that act concomitantly to influence 
the magnitude of drug absorption. 
2.reduced fluctution of drug concentration:contineous 
input of  following CRGRDF administration produce blood 
drug concentration within narrower ranged campared to 
immediate release dosage form. 
3.Site-Specific Drug Delivery.  Furosemide is primarily 
absorbed from the stomach followed by the duodenum10 
4. Sustained Drug Delivery: 
These systems have a bulk density of <1 as a result of which 
they can float on the gastric contents. These systems are 
relatively large in size and passing from the pyloric opening 
is prohibited. 
5. Minimized adverse activity at the colon: 
The polymers described as pH dependent in colon specific 
drug delivery are insoluble at low pH levels but become 
increasingly soluble as pH rise Thus, undesirable activities of 
the drug in colon may be prevented.7 
Conclusion 
Effervescent floating tablet are an interesting 
pharmaceutical dosage form offering some unique 
advantages compared with traditional or conventional 
tablets. The manufacturing process involves some critical 
steps that need to be addressed carefully during  
formulation. FDDS provide to be a potential approach for 
gastric retention. 
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